Koninklijke Philips (PHG)
(Delayed Data from NYSE)
$30.58 USD
-0.33 (-1.07%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $30.58 0.00 (0.00%) 6:40 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PHG 30.58 -0.33(-1.07%)
Will PHG be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PHG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHG
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
PHG: What are Zacks experts saying now?
Zacks Private Portfolio Services
ICU Medical, Inc. (ICUI) Hits Fresh High: Is There Still Room to Run?
Is Baxter International (BAX) Stock Undervalued Right Now?
PHG or ESLOY: Which Is the Better Value Stock Right Now?
Other News for PHG
Kepler Capital Remains a Buy on Koninklijke Philips N.V. (0LNG)
Vivos surges on FDA nod for pediatric sleep apnea device
Jefferies Reaffirms Their Sell Rating on Koninklijke Philips N.V. (0LNG)
Philips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology
Philips announces FDA approval for enhance LumiGuide guidewire